Reuters logo
BRIEF-‍GlaxoSmithKline reports 13.3 percent stake in Spero Therapeutics
November 16, 2017 / 10:33 PM / a month ago

BRIEF-‍GlaxoSmithKline reports 13.3 percent stake in Spero Therapeutics

Nov 16 (Reuters) - Spero Therapeutics Inc

* ‍GlaxoSmithKline PLC reports a 13.3 percent stake in Spero Therapeutics Inc as of November 6 - SEC filing​ Source text: (bit.ly/2infUEI) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below